Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Expression of Elafin in Dermatitis Herpetiformis.

Ollague JE, Nousari CH.

Am J Dermatopathol. 2018 Jan;40(1):1-6. doi: 10.1097/DAD.0000000000000915.

PMID:
29293478
2.

A commensal Bifidobacterium longum strain improves gluten-related immunopathology in mice through expression of a serine protease inhibitor.

McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, Duboux S, Steinmann M, Delley M, Tangyu M, Langella P, Mercenier A, Bergonzelli G, Verdu EF.

Appl Environ Microbiol. 2017 Aug 4. pii: AEM.01323-17. doi: 10.1128/AEM.01323-17. [Epub ahead of print]

3.

Pharmacological approaches in celiac disease.

McCarville JL, Caminero A, Verdu EF.

Curr Opin Pharmacol. 2015 Dec;25:7-12. doi: 10.1016/j.coph.2015.09.002. Epub 2015 Sep 27. Review.

PMID:
26414923
4.

Use of elafin in celiac disease.

Kav T.

Turk J Gastroenterol. 2015 Jan;26(1):93-4. doi: 10.5152/tjg.2015.0115. No abstract available.

5.

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

Galipeau HJ, Wiepjes M, Motta JP, Schulz JD, Jury J, Natividad JM, Pinto-Sanchez I, Sinclair D, Rousset P, Martin-Rosique R, Bermudez-Humaran L, Leroux JC, Murray JA, Smecuol E, Bai JC, Vergnolle N, Langella P, Verdu EF.

Am J Gastroenterol. 2014 May;109(5):748-56. doi: 10.1038/ajg.2014.48. Epub 2014 Apr 8.

Supplemental Content

Loading ...
Support Center